论文部分内容阅读
目的观察沙美特罗氟替卡松粉吸入剂(舒利迭)在治疗儿童哮喘中的临床疗效.方法将200例患有哮喘的儿童随机分为研究组和对照组,每组100例,所有患儿均停用原来治疗哮喘的药物,观察组给予沙美特罗氟替卡松粉吸入剂,对照组给予氟替卡松(辅舒酮)进行治疗.结果观察组总有效率为98%,对照组总有效率80%,两组比较差异有显著性(χ2=7.072,P<0.01).结论沙美特罗氟替卡松粉吸入剂(舒利迭)治疗儿童哮喘疗效显著.“,”Objective To observe the clinical effects of Salmeterol fluticasone propionate powder inhalation in the treatment of children asthma. Methods The 200 children who suffered from asthma were divided randomly into two groups: study group and control group. Each group has 100 cases. Study group was given Salmeterol fluticasone propionate powder in -halation. Control group was given Flixotide. The effective rate of study group is up to 98%. Meanwhile the effective rate in control group is 80%. Al the difference had statistics significance (χ2=7.072, P<0.01).Conclusion Salmeterol fluticas-one propionate powder inhalation has good effect on treatment of children asthma.